Literature DB >> 10567569

Distinct cellular factors regulate the c-myb promoter through its E2F element.

M R Campanero1, M Armstrong, E Flemington.   

Abstract

Most E2F-driven promoters are transiently activated around the G(1)/S transition. Although the promoter for the c-myb proto-oncogene harbors an E2F element, it is induced early in G(1) following entry into the cell cycle. Furthermore, this promoter remains active throughout subsequent cell cycles. Since E2F sites function as repressor elements during G(1) (due to the association of pRb with E2F factors), we investigated whether the E2F element in the c-myb promoter is regulated differently than E2F elements in promoters that are repressed during G(1). By gel shift analysis, the E2F element from the c-myb promoter was found to form a unique complex, referred to as E2Fmyb-sp, which was not observed with E2F elements from several other promoters. Antibodies to DP-1, E2F1 to -5, p107, or pRb failed to either supershift or block E2Fmyb-sp complex formation. Methylation interference experiments indicate that the DNA contact residues for the E2Fmyb-sp complex are distinct from but overlapping with residues required for the binding of E2F proteins. In addition to the identification of E2Fmyb-sp, we have found that SP-1 binds to the c-myb E2F element. Functional studies revealed that E2Fmyb-sp and/or SP-1 are required to achieve full activation of the c-myb promoter in different cell types and to maintain elevated expression of the c-myb promoter during G(1) in NIH 3T3 cells. These studies demonstrate that E2F elements can be regulated differently through the binding of unique sets of proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567569      PMCID: PMC84947          DOI: 10.1128/MCB.19.12.8442

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  71 in total

1.  A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.

Authors:  H Singh; R Sen; D Baltimore; P A Sharp
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

2.  Expression of the c-myb oncogene in human small cell lung carcinoma.

Authors:  C A Griffin; S B Baylin
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

3.  Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein.

Authors:  R Fagan; K J Flint; N Jones
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

4.  Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.

Authors:  D G Johnson; K Ohtani; J R Nevins
Journal:  Genes Dev       Date:  1994-07-01       Impact factor: 11.361

5.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

6.  Expression of cellular oncogenes in human malignancies.

Authors:  D J Slamon; J B deKernion; I M Verma; M J Cline
Journal:  Science       Date:  1984-04-20       Impact factor: 47.728

7.  Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia.

Authors:  P G Pelicci; L Lanfrancone; M D Brathwaite; S R Wolman; R Dalla-Favera
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

8.  Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma.

Authors:  K Alitalo; R Winqvist; C C Lin; A de la Chapelle; M Schwab; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation.

Authors:  J Yokota; Y Tsunetsugu-Yokota; H Battifora; C Le Fevre; M J Cline
Journal:  Science       Date:  1986-01-17       Impact factor: 47.728

10.  Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter.

Authors:  E Neuman; E K Flemington; W R Sellers; W G Kaelin
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

View more
  18 in total

1.  CpG methylation as a mechanism for the regulation of E2F activity.

Authors:  M R Campanero; M I Armstrong; E K Flemington
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Expression of Dmp1 in specific differentiated, nonproliferating cells and its regulation by E2Fs.

Authors:  A Mallakin; P Taneja; L A Matise; M C Willingham; K Inoue
Journal:  Oncogene       Date:  2006-07-31       Impact factor: 9.867

Review 3.  Regulation of cellular miRNA expression by human papillomaviruses.

Authors:  Zhi-Ming Zheng; Xiaohong Wang
Journal:  Biochim Biophys Acta       Date:  2011-05-17

4.  c-Myb transcription is activated by protein kinase B (PKB) following interleukin 2 stimulation of Tcells and is required for PKB-mediated protection from apoptosis.

Authors:  A Lauder; A Castellanos; K Weston
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

5.  Functional evolution of the vertebrate Myb gene family: B-Myb, but neither A-Myb nor c-Myb, complements Drosophila Myb in hemocytes.

Authors:  Colin J Davidson; Rabindra Tirouvanziam; Leonard A Herzenberg; Joseph S Lipsick
Journal:  Genetics       Date:  2004-10-16       Impact factor: 4.562

6.  E2F-1 has dual roles depending on the cell cycle.

Authors:  Fikret Sahin; Todd L Sladek
Journal:  Int J Biol Sci       Date:  2010-03-03       Impact factor: 6.580

7.  Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer.

Authors:  Jin Zhao; Xin-Yang Wu; Xiao-Hui Ling; Zhuo-Yuan Lin; Xin Fu; Ye-Han Deng; Hui-Chan He; Weide Zhong
Journal:  Med Oncol       Date:  2013-02-03       Impact factor: 3.064

8.  Identification of a negative regulatory element in the Epstein-Barr virus Zta transactivation domain that is regulated by the cell cycle control factors c-Myc and E2F1.

Authors:  Zhen Lin; Qinyan Yin; Erik Flemington
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma.

Authors:  Irene Molina-Privado; María Rodríguez-Martínez; Patricia Rebollo; Daniel Martín-Pérez; María-Jesús Artiga; Javier Menárguez; Erik K Flemington; Miguel A Piris; Miguel R Campanero
Journal:  Cancer Res       Date:  2009-05-01       Impact factor: 12.701

Review 10.  Mechanisms involved in Burkitt's tumor formation.

Authors:  M R Campanero
Journal:  Clin Transl Oncol       Date:  2008-05       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.